Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02311270 · ClinicalTrials.gov registry record
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 106
- Enrollment target
NCT02311270: Completed study, sponsored by University of South Florida.
NCT02311270 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02311270 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-06 |
What the finished NCT02311270 record still lists
NCT02311270 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02311270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02311270 about?
NCT02311270 is a clinical study titled "Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation". The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.
What is the current status of trial NCT02311270?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2014-09. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02311270?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia